Hospital Mergers and the Economics of Consolidation

Walk through almost any American city today and there’s a good chance most of its hospitals belong to just one or two large health systems. This is hospital consolidation: independent hospitals merging into, or being acquired by, larger systems, sometimes spanning dozens of facilities across several states. It’s been happening for decades, and it reshapes healthcare economics in ways that reach far beyond any single building.

The case hospitals make for merging

Hospital executives typically justify a merger with the promise of economies of scale - the idea that a larger organization can spread fixed costs like billing systems, electronic health records, and specialized equipment across more patients, lowering the average cost per patient. A larger system can also standardize supply purchasing, negotiate better prices on everything from surgical equipment to pharmaceuticals, and shift patients to whichever facility in the network has available capacity, easing strain during a surge like a bad flu season. Struggling rural hospitals sometimes merge specifically to survive at all, since a larger parent system can absorb losses that would sink a standalone hospital.

Where the leverage actually goes

The trouble is what happens to market concentration - how much of a local hospital market is controlled by a shrinking number of players - once a merger goes through. Health insurers negotiate prices with hospitals the same way any buyer negotiates with any seller: leverage depends on whether the buyer has other options. When several independent hospitals compete in one region, an insurer that can’t reach a deal with one can steer patients toward another. Once those hospitals merge into a single system, that alternative disappears, and the merged system gains substantially more bargaining leverage - the negotiating power that comes from being difficult, or impossible, to replace.

Extensive research on hospital mergers has found a fairly consistent pattern: prices charged to insurers rise significantly after a merger, often in the range of twenty to forty percent within a region where the merger meaningfully increased concentration, while the promised cost savings frequently fail to reliably show up, or show up on paper without ever reaching patients’ bills.

Effects beyond price

Consolidation can also change which services survive in a given community. A large system may consolidate specialized services - maternity care or a trauma center, for instance - into fewer locations to concentrate expertise and cut duplicate overhead, which can improve care quality at the remaining sites but also lengthen travel times for patients elsewhere, echoing the access tradeoffs discussed in this module’s telemedicine lesson. Consolidation has also extended beyond hospital-to-hospital mergers into hospitals acquiring physician practices directly, which shifts many outpatient visits onto hospital billing rates - often considerably higher than an independent physician’s office would charge for the identical service.

What regulators try to do about it

Antitrust regulators can, and sometimes do, block hospital mergers that would create excessive concentration in a local market, similar to how antitrust law scrutinizes mergers in any other industry. But healthcare markets are defined narrowly and locally - a hospital forty-five minutes away often isn’t a realistic substitute for a patient needing emergency care - which makes drawing the line around what counts as one “market” genuinely difficult, and enforcement inconsistent across regions and administrations.